NTRB — Nutriband Income Statement
0.000.00%
- $87.34m
- $84.55m
- $2.14m
Annual income statement for Nutriband, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.944 | 1.42 | 2.08 | 2.09 | 2.14 |
Cost of Revenue | |||||
Gross Profit | 0.361 | 0.504 | 0.75 | 0.862 | 0.743 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3.62 | 7.48 | 6.55 | 7.51 | 12.8 |
Operating Profit | -2.67 | -6.06 | -4.48 | -5.43 | -10.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.93 | -6.18 | -4.48 | -5.49 | -10.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.93 | -6.18 | -4.48 | -5.49 | -10.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.93 | -6.18 | -4.48 | -5.49 | -10.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.93 | -6.37 | -4.48 | -5.49 | -10.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.424 | -0.535 | -0.491 | -0.62 | -0.615 |